Php50 - Price Regulation Ordinance Impact on Reimbursed Prices for Mostly Prescribed Medicines in Bosnia and Herzegovina

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.945
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bosnia and Herzegovina

IMF Staff Country Reports
2020English

Determinants of Market Prices of Shares on the Capital Market of Bosnia and Herzegovina

Bankarstvo
2017English

Budget Impact of Publicly Reimbursed Prescription Medicines in the Republic of Srpska

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2015English

The Impact of Brand Name on Consumers, Case of Bosnia and Herzegovina

European Journal of Economics and Business Studies
2015English

Assessing the Impact of Prescribed Medicines on Health Outcomes

Australia and New Zealand Health Policy
2007English

Information Security in Bosnia and Herzegovina

FBIM Transactions
2019English

Utilizing Information Systems for Measuring Impact on Social Sustainability: Survey of Microcredit Organizations in Bosnia and Herzegovina

Journal of Economic and Social Studies
2012English

PHP9 Drug Pricing in Bosnia and Herzegovina

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Foreign Direct Investment Impact on Market Concentration in the Manufacturing Sector of Bosnia and Herzegovina

Facta Universitatis, Series: Economics and Organization
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy